Inventor
ZHANG WEIHONG
US33 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG WEIHONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE CORP
21 patentsUS9828361B2Nov 28, 2017
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP12 citations92
US7511072B2Mar 31, 2009
7-amido-isoindolyl compounds and methods of its use
CELGENE CORP16 citations92
US7256210B2Aug 14, 2007
7-amido-isoindolyl compounds and methods of their use
CELGENE CORP24 citations92
US7173058B2Feb 6, 2007
Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
CELGENE CORP20 citations92
US7034052B2Apr 25, 2006
7-Amido-isoindolyl compounds and their pharmaceutical uses
CELGENE CORP32 citations92
US9822094B2Nov 21, 2017
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP9 citations84
US9309219B2Apr 12, 2016
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP8 citations84
US10189808B2Jan 29, 2019
Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
CELGENE CORP10 citations81
US7504427B2Mar 17, 2009
Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
CELGENE CORP5 citations74
US10189814B2Jan 29, 2019
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP2 citations73
US7893102B2Feb 22, 2011
Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
CELGENE CORP2 citations63
US11414399B2Aug 16, 2022
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP0 citations62
US12577223B2Mar 17, 2026
Processes for preparing 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
CELGENE CORP0 citations59
US12435028B2Oct 7, 2025
Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate
CELGENE CORP0 citations59
US11912644B2Feb 27, 2024
Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate
CELGENE CORP0 citations59
US11505522B2Nov 22, 2022
Processes for the preparation of (S)-tert-butyl 4,5- diamino-5-oxopentanoate
CELGENE CORP0 citations59
US11401257B2Aug 2, 2022
Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
CELGENE CORP0 citations59
US11312699B2Apr 26, 2022
Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
CELGENE CORP0 citations59
US10669257B2Jun 2, 2020
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
CELGENE CORP0 citations52
US7799819B2Sep 21, 2010
7-Amido-isoindolyl compounds and their pharmaceutical uses
CELGENE CORP0 citations52
US10717703B2Jul 21, 2020
Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate
CELGENE CORP0 citations48
MULLER GEORGE W
2 patentsNIKOVSKI DANIEL N
2 patentsUS8566266B2Oct 22, 2013
Method for scheduling the operation of power generators using factored Markov decision process
NIKOVSKI DANIEL N8 citations82
US8996185B2Mar 31, 2015
Method for scheduling power generators based on optimal configurations and approximate dynamic programming
NIKOVSKI DANIEL N2 citations61